Reading time is 4 mins
.
.
TURKISH SCIENTISTS HAVE DEVELOPED ARTIFICIAL INTELLIGENCE SOFTWARE THAT CAN DETECT COVID-19 IN 50 SECONDS ON COMPUTED TOMOGRAPHY
Head of Radiology Department of IUC Faculty of Medicine Turkish Prof. Dr. “With the software developed, we were able to develop a system that informed us that there were positive findings of Covid in the patient at the time of withdrawal, with 95 percent accuracy.” was said.
Istanbul University, Cerrahpasa (IUC), Cerrahpasa Medical Faculty, Sabanci University and TUBITAK National Metrology Institute by thoracic computed tomography (CT) in the lungs developed artificial intelligence software to be used with a new type of coronavirus (Covid-19) involvement can be determined with 95 percent accuracy rate in 50 seconds.
Head of Radiology Department of IUC Cerrahpaşa Medical Faculty Prof. Dr. Osman Kızılkılıç, AA correspondent said in a statement, covid-19 patients to take isolation measures to start drug treatment, if necessary to make hospital admissions to their hands to make a quick diagnosis PCR test, computed tomography and lung X-ray reminded that.
Computed tomography, a method is preferred because it is much lighter review shows that attitudes especially transmits, therefore, this method of how they could make it faster, or how daily positive patients expressed that they thought once in the workflow.
In this context, Sabancı University, Prof. Dr. He explained the team evaluated the images of the patients together, read them by radiology and summarized the Radiological findings in these patients, and Sabanji University supported them on the computer and machine learning side.
Prof. Dr. “With the software developed, we have been able to develop a system that informs us that there are positive findings of covid in the patient at the moment of withdrawal, gives a preliminary report to the doctor, warns the doctor with 95 percent accuracy in about 50 seconds,” said he gave his information.
“The main goal here is to make a quick diagnosis to the patient, to make the correct diagnosis, to make the correct diagnosis on the basis of the patient, to make the patient in the form of a customized diagnosis,” said Kızılkılıç, who said that 8 people from Cerrahpaşa and 5 people from Sabancı University had worked in the project. For this reason, this software can be further developed, it can be used for lung cancer screening, nodule screening, mammograms for breast cancer. What is being tried to do with all this software is to give patients the correct diagnosis faster., “he said.
Kızılkılıç stated that after the developed software becomes a prototype, it can become commercial software or become a project that can be made available to the common use of humanity.
Kızılkılıç said that the clinical studies of the project are continuing, ” we are currently continuing their medical processes, but we are currently using it because the clinic has now achieved 95 percent success.” said.
It aims to bring the accuracy of the project closer to 100 percent
Sabancı University Computer Science and engineering program faculty member Prof. Dr. pointed out that at the end of March 2021, the Istanbul Development Agency had a call for research against covid-19.
IUC and TÜBITAK National Metrology Institute began to work together after they came to them with a common idea, 8-9 months in a period such as this system developed, he said.
Stating that they will continue to develop the software, said: “the current seconds, that is, work under 1 minute is already very, very enough for us. At that time, the patient doesn’t even leave the room. So it’s not speeding up, but how much closer can we get to 100 percent, we can try to improve its accuracy., “he said “it was very enjoyable to do something that would help doctors, also thanked his students who worked on the project.
.
IT OFFERS A GREAT ADVANTAGE IN ENSURING EARLY ISOLATION
Turkey IUC Cerrahpaşa Faculty of Medicine Department of Radiology faculty member Assoc. Dr. admitted in the emergency room with respiratory distress and Kovid-19 is suspected, patients were asked to review the lung from CT, but CT images, and the number of patients examined in the ER is high in hospitals where the physician radiology to provide information to are able to find a few hours of the process are explained.
Doctor, who said that they set out with the desire to create solution to this problem, gave the following information about the working model of the artificial intelligence software developed:
“Immediately after the CT scan of the patient with suspected Kovid-19 is taken, the CT images of the patient are transmitted to the artificial intelligence software, and after scanning the images, if the findings of Kovid-19 are present, it sends a warning about the patient to the automation system of our hospital. This warning sent by the software can be seen by both the doctor who directs the patient to the tomography, the radiology technician who performs the tomography, and the radiology physicians who will report the tomography. This entire process is completed in less than 1 minute, an average of 45-50 seconds. In this way, the warning of the artificial intelligence system provides rapid isolation of the patient while he is still in the tomography shooting room. In addition, it is possible to evaluate the CT scans of patients whose system has given Covid warning by radiology physicians as a priority and inform the emergency department physician and start the treatment of these patients earlier. It gives us a huge advantage in ensuring isolation early.”
In Turkey computed tomography devices, they aim at the continuous development and medical conditions in accordance with the system of artificial intelligence, especially in Turkey hospitals with a density sick think that it would be very useful, therefore, they were spread throughout the country, was added.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.